SCHEMBL246672

SCHEMBL246672

C=C(C)C(=O)OC(C)NCC

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.44
ALDH1A1 P00352 2/20 0.43
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23116685 0.98 TSHR (0.42) TSHRALDH1A1THRB
Ammonia Solution, Strong SCHEMBL7765025 0.98 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL556918 0.85 TSHR (0.41) TSHRALDH1A1THRB
SCHEMBL5576920 0.84 TSHR (0.44) TSHRALDH1A1THRB
SCHEMBL6264346 0.82 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL28964247 0.82 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL3280963 0.82 TSHR (0.47) TSHRALDH1A1THRB
SCHEMBL331326 0.82 TSHR (0.43) TSHRALDH1A1THRB
SCHEMBL1997755 0.82 TSHR (0.39) TSHRALDH1A1THRB
SCHEMBL11345816 0.81 TSHR (0.41) TSHRALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3890685-B1 COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE ENCAPSYS LLC (US) 2026-03-11 EP claimed
US-12312566-B2 Compositions comprising benefit agent containing delivery particle ENCAPSYS, LLC (US) 2025-05-27 US claimed
US-12146124-B2 Benefit-agent-containing delivery particles having high core to wall ratios ENCAPSYS, LLC (US) 2024-11-19 US claimed
CN-112638352-B Composition comprising benefit agent-containing delivery particles 恩盖普有限公司 2024-05-07 CN claimed
CN-113164789-B Composition comprising an encapsulate 宝洁公司 2024-01-09 CN claimed
EP-4247895-A1 POLY ACRYLATE AND POLY(BETA-ESTER) CAPSULES WITH ENHANCED DEGRADABILITY Encapsys, LLC (US) 2023-09-27 EP claimed
CN-116472303-A Polyacrylate and poly (beta-ester) capsules with improved degradability 恩盖普有限公司 2023-07-21 CN claimed
WO-2022109112-A1 POLY ACRYLATE AND POLY(BETA-ESTER) CAPSULES WITH ENHANCED DEGRADABILITY ENCAPSYS, LLC (US) 2022-05-27 WO claimed
EP-4000725-A1 CONSUMER PRODUCT COMPRISING POLY ACRYLATE AND POLY(BETA-AMINO ESTER) DELIVERY CAPSULES WITH ENHANCED DEGRADABILITY The Procter & Gamble Company (US) 2022-05-25 EP claimed
US-20220153901-A1 Poly Acrylate and Poly(Beta-Amino Ester) Capsules with Enhanced Degradability Encapsys,LLC (US) 2022-05-19 US claimed
WO-2001027178-A1 PROCESS FOR THE PREPARATION OF ANIONIC AQUEOUS POLYMER DISPERSIONS CONTAINING NO VOLATILE TERTIARY AMINE, OBTAINED DISPERSION AND COATING RESULTING FROM SAID DISPERSION STAHL INTERNATIONAL B.V. (NL) 2001-04-19 WO claimed
US-5047287-A Acrylonitrile-isoprene or butadiene/1,3-/ copolymer having amino group as adhesive TOYODA GOSEI CO., LTD. (JP) 1991-09-10 US claimed
EP-0262242-B1 PHOTO-CURABLE COMPOSITION Nippon Paint Co., Ltd. (JP) 1991-01-16 EP claimed
US-4340523-A Electrocoating composition with polyhydroxyamine and epoxy E. I. DUPONT DE NEMOURS AND COMPANY (US) 1982-07-20 US claimed
US-4338236-A CATIONIC POLYMERS CURABLE AT RELATIVELY LOW TEMPERATURE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-07-06 US claimed
US-4338235-A Electrocoating composition with polyhydroxyamine and acrylic or methacrylic polymers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-07-06 US claimed
US-4337187-A PAINTS E. I. DUPONT DE NEMOURS AND COMPANY (US) 1982-06-29 US claimed
US-4335031-A PRIMERS FOR COATINGS ON AUTOMOBILES AND TRUCKS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-06-15 US claimed
EP-0032570-A2 Graft copolymer, a coating composition comprising same and the process for electrocoating such compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-07-29 EP claimed
US-3977983-A Liquid developer for use in development of an electrostatic latent image comprising a copolymer containing an amino group converted into a quaternary ammonium salt or hydroxide CANON KABUSHIKI KAISHA (JA) 1976-08-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153901-A1 Poly Acrylate and Poly(Beta-Amino Ester) Capsules with Enhanced Degradability APEH, PDGFA, ABHD6 TSHR 3307/4885ALDH1A1 1884/4885THRB 808/4885
US-12312566-B2 Compositions comprising benefit agent containing delivery particle APOB, CHMP4B, HDLBP TSHR 3757/4885ALDH1A1 2300/4885THRB 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.